CEFTRIAXONE SODIUM FOR INJECTION BP
SANDOZ CANADA INCORPORATED
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of CEFTRIAXONE SODIUM FOR INJECTION BP in Canada?
Yes. CEFTRIAXONE SODIUM FOR INJECTION BP 2G has an active shortage reported to Health Canada (last updated September 8, 2026).
Why is CEFTRIAXONE SODIUM FOR INJECTION BP not available?
The reason the manufacturer reported: Disruption of the manufacture of the drug.
When will CEFTRIAXONE SODIUM FOR INJECTION BP be available again?
The estimated resolution date (September 4, 2026) has passed, but the report has not been updated yet. Follow this page to get an email when the status changes.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
ROCEPHIN PWS 2GM/VIAL
HOFFMANN-LA ROCHE LIMITED
SANDOZ CEFTRIAXONE
SANDOZ CANADA INCORPORATED
Other Products
ROCEPHIN PWS INJ 0.25GM/VIAL
HOFFMANN-LA ROCHE LIMITED
ROCEPHIN PWS 1GM/VIAL
HOFFMANN-LA ROCHE LIMITED
ROCEPHIN INJ 10GM/VIAL
HOFFMANN-LA ROCHE LIMITED
ROCEPHIN PWS INJ 1GM/VIAL
HOFFMANN-LA ROCHE LIMITED
What this means
Does this mean my pharmacy is out of stock?
Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.
What should I do?
Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.
Estimated Resolution
2026-09-04
This is the manufacturer's estimated date, not a guarantee — actual resolution may come earlier or later.
DIN
02292289
Strength
2G
Dosage Form
POWDER FOR SOLUTION
Route
INTRAVENOUS INTRAMUSCULAR
Active Ingredient
CEFTRIAXONE
Tier
Unrated
Last Updated
2026-09-08
Reason for Shortage
Disruption of the manufacture of the drug.
Other Products from SANDOZ CANADA INCORPORATED
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
200MG · DIN 02243098
5MG · DIN 02269198
500MCG · DIN 02248181
250MG · DIN 02242971
50MG · DIN 02242325
DIN 02495929
DIN 02495937
DIN 02495910
250MG · DIN 02246533
1MG · DIN 02548968
10MG · DIN 02513420
10MG · DIN 02236759